EP Patent

EP1413331A3 — Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) for vascular indications

Assigned to Merck Sharp and Dohme LLC · Expires 2004-06-30 · 22y expired

What this patent protects

The present invention relates to compositions comprising at least one peroxisome proliferator-activated receptor activator and at least one sterol absorption inhibitor with a specific structure.

USPTO Abstract

The present invention relates to compositions comprising at least one peroxisome proliferator-activated receptor activator and at least one sterol absorption inhibitor with a specific structure.

Drugs covered by this patent

Patent Metadata

Patent number
EP1413331A3
Jurisdiction
EP
Classification
—
Expires
2004-06-30
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.